March 25, 2020
Nippon Boehringer Ingelheim launched a voluntary recall of its anti-allergy drug Alesion Tablets 20 (epinastine) after it found an unacceptable level of impurities in the API. No health damage has been reported, it said. The recall falls under the category...read more